Martha J. Carter
Net Worth

Last updated:

What is Martha J. Carter net worth?

The estimated net worth of Ms. Martha J. Carter is at least $4,387,201 as of 23 Jan 2023. She has earned $658,551 from insider trading and has received compensation worth at least $3,728,650 in Albireo Pharma, Inc..

What is the salary of Martha J. Carter?

Ms. Martha J. Carter salary is $745,730 per year as Chief Regulatory Officer in Albireo Pharma, Inc..

How old is Martha J. Carter?

Ms. Martha J. Carter is 73 years old, born in 1952.

What stocks does Martha J. Carter currently own?

As insider, Ms. Martha J. Carter owns shares in one company:

Company Title Shares Price per share Total value
Albireo Pharma, Inc. (ALBO) Chief Regulatory Officer 14,506 $0 $0

What does Albireo Pharma, Inc. do?

Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as well as in Phase III clinical trial for treating biliary atresia, alagille syndrome, and rare and life-threatening disorder to children; and Elobixibat for the treatment of chronic constipation and other functional diseases. It also engages in the developing of A3907, which is in Phase I clinical trial for the treatment of adult liver diseases; and A2342, a preclinical candidate to treat adult viral and liver diseases. The company has a license agreement with EA Pharma Co., Ltd. for the development and commercialization of elobixibat. Albireo Pharma, Inc. is headquartered in Boston, Massachusetts.

ALBO logo
ALBO
Albireo Pharma, Inc.

Martha J. Carter insider trading

Albireo Pharma, Inc.

Ms. Martha J. Carter has made 11 insider trades between 2020-2023, according to the Form 4 filled with the SEC. Most recently she sold 120 units of ALBO stock worth $5,256 on 23 Jan 2023.

The largest trade she's ever made was exercising 10,000 units of ALBO stock on 8 Sep 2020. As of 23 Jan 2023 she still owns at least 14,506 units of ALBO stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 120 $43.8 $5,256
Sale
Common Stock 938 $43.9 $41,182
Sale
Common Stock 104 $19.58 $2,036
Sale
Common Stock 106 $24.68 $2,616
Sale
Common Stock 103 $32.93 $3,391
Sale
Common Stock 423 $24.52 $10,370
Option
Stock Option (right to buy) 10,000 $27.12 $271,200
Option
Stock Option (right to buy) 10,000 $14.88 $148,800
Option
Common Stock 10,000 N/A N/A
Option
Common Stock 10,000 $27.12 $271,200
Sale
Common Stock 10,000 $40.03 $400,300
Sale
Common Stock 10,000 N/A N/A
Option
Stock Option (right to buy) 10,000 N/A N/A
Option
Common Stock 10,000 N/A N/A
Option
Stock Option (right to buy) 10,000 $24.26 $242,600
Option
Common Stock 10,000 $24.26 $242,600
Option
Common Stock 10,000 $39.25 $392,500
Sale
Common Stock 10,000 N/A N/A
Option
Stock Option (right to buy) 10,000 N/A N/A
Sale
Common Stock 10,000 $19.34 $193,400
Option
Common Stock 10,000 $39.25 $392,500
Option
Stock Option (right to buy) 10,000 $19.91 $199,100
Option
Common Stock 10,000 N/A N/A
Sale
Common Stock 10,000 N/A N/A

Albireo Pharma key executives

Albireo Pharma, Inc. executives and other stock owners filed with the SEC: